AxoGen, Inc. Forecast, price target & analysts
AxoGen, Inc. Target price 2026 - Analyst rating & recommendation
AxoGen, Inc. Classifications & Recommendation
AxoGen, Inc. Price Target
| Target Price | $56.10 |
| Price | $43.32 |
| Potential |
29.50%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target AxoGen, Inc. 2027 .
The average AxoGen, Inc. target price is $56.10.
This is
29.50%
register free of charge
$63.00
45.43%
register free of charge
$48.48
11.91%
register free of charge
|
|
| A rating was issued by 16 analysts: 15 Analysts recommend AxoGen, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AxoGen, Inc. stock has an average upside potential 2027 of
29.50%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 225.21 | 285.15 |
| 20.21% | 26.62% | |
| EBITDA Margin | -0.39% | 11.47% |
| 120.98% | 3,069.15% | |
| Net Margin | -6.97% | 8.91% |
| 31.12% | 227.81% |
12 Analysts have issued a sales forecast AxoGen, Inc. 2026 . The average AxoGen, Inc. sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an AxoGen, Inc. EBITDA forecast 2026. The average AxoGen, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 AxoGen, Inc. Analysts have issued a net profit forecast 2026. The average AxoGen, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.34 | 0.47 |
| 47.83% | 238.24% | |
| P/E | 91.47 | |
| EV/Sales | 8.52 |
12 Analysts have issued a AxoGen, Inc. forecast for earnings per share. The average AxoGen, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current AxoGen, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | Aug 26 2026 |
| Citizens |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Apr 29 2026 |
| Citizens |
Locked
➜
Locked
|
Locked | Apr 29 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 29 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 26 2026 |
|
Locked
Citizens:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Apr 29 2026 |
|
Locked
Citizens:
Locked
➜
Locked
|
Apr 29 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 29 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
